Skip to content

A retrospective cohort study on the preventive effect of Lianhua Qingwen capsule/granule on the isolated population of novel coronavirus pneumonia

A retrospective cohort study on the preventive effect of Lianhua Qingwen capsule/granule on the isolated population of novel coronavirus pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063524
Enrollment
Unknown
Registered
2022-09-09
Start date
2022-09-09
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Lian-Hua Qing-Wen Capsule Group:Lian-Hua Qing-Wen Capsule,4 capsules/time, 3 times a day
Isolated observation control group:Isolated observation

Sponsors

Jilin Province People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who were confirmed to be in need of centralized medical isolation after the epidemiological investigation of the new coronavirus pneumonia; 2. Male or female patients aged over 18, inclusive(>= 18).

Exclusion criteria

Exclusion criteria: 1. Patients with a positive result on a nucleic acid test, diagnosed as asymptomatic infection or confirmed case of new coronavirus pneumonia; 2. Patients with a positive result on a nucleic acid test on the day of entering the isolation point; 3. Staff and volunteers at the isolation point; 4. Covid-19 patients were isolated after they turned to negative result on a nucleic acid test; 5. Stranded personnel.

Design outcomes

Primary

MeasureTime frame
Nucleic acid test positive rate of nasal and throat swabs during the isolation medical observation period;

Countries

China

Contacts

Public ContactWang Yongjie, Qiao Yunfeng
1941266019@qq.com+86 13404799977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026